Mark Lachovsky, founder and president of Accel Pharma, a Canadian generics company with a unique business model, discusses the inspiring story of how he started and grew the company through challenging times, the important role Accel plays in providing affordable generics drugs to the Canadian population, and his international partnership strategy.
Mark, as the founder and president of Accel Pharma, could you first introduce the company to our international audience?
"Political change continues to be a significant issue facing the generics sector and our business model."
